Compare BBIO & EMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBIO | EMA |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 14.9B |
| IPO Year | 2019 | N/A |
| Metric | BBIO | EMA |
|---|---|---|
| Price | $65.88 | $51.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 22 | 0 |
| Target Price | ★ $79.91 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 244.2K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $85.55 | N/A |
| Revenue Next Year | $71.10 | $9.71 |
| P/E Ratio | ★ N/A | $19.19 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $28.33 | $43.90 |
| 52 Week High | $84.94 | $52.82 |
| Indicator | BBIO | EMA |
|---|---|---|
| Relative Strength Index (RSI) | 36.59 | 57.68 |
| Support Level | $61.54 | $47.28 |
| Resistance Level | $68.71 | N/A |
| Average True Range (ATR) | 4.46 | 1.05 |
| MACD | -0.77 | 0.06 |
| Stochastic Oscillator | 17.00 | 58.22 |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.